Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Century Therapeutics Logo
Century Therapeutics Growth Score
80
CB Rank
4484
Heat Score
44
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Founded
obfuscation
PublicPost-IPO Equity Philadelphia, Pennsylvania, United States101-250 www.centurytx.com
Biotechnology
Health Care
Health Diagnostics
Overview

Century Therapeutics
Total Funding
obfuscation
Growth Score
80
Heat Score
44

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score80
4 pts
in past quarter
Heat Score 44
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Century Therapeutics

CB Rank
4484
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Founded
obfuscation
PublicPost-IPO Equity Philadelphia, Pennsylvania, United States101-250 www.centurytx.com
Biotechnology
Health Care
Health Diagnostics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Century Therapeutics Inc.
Operating Status Active
Stock Symbol  NASDAQ:IPSC
Company Type For Profit
Founders  Marcela Maus
About the Company
Century Therapeutics builds an allogeneic iPSC-derived cell therapy platform that integrates gene editing, protein engineering, technical development, and manufacturing capabilities to generate allogeneic, iPSC-derived NK and T cell therapies for both hematological and solid tumor malignancies with significant unmet medical needs.
Phone Number +1 267 857 1080
Contact Email media@centurytx.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Insight

See this Growth Insight
Century Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

CNTY-101 iNK 1.0
An allogeneic, iPSC-derived natural killer cell therapy targeting CD19 for treating B-cell-mediated autoimmune diseases.
CNTY-308 αβ iT 5.0
An allogeneic, iPSC-derived αβ T cell therapy targeting CD19 for B-cell-mediated autoimmune diseases and B-cell malignancies.

Research & Development

Century Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity
obfuscation
Post-IPO Equity - Century Therapeutics Logo
Post-IPO Equity - Century Therapeutics
7
obfuscation
TCG CrossoverPost-IPO Equity

Investors

Investments

Number of Acquisitions 2

Investment Breakdown

Number of Acquisitions 2
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 6 Board Members and Advisors 5 Contacts 175

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

3,105
82%
 in past month

IT Spend

$8.8MThis year, Century Therapeutics is projected to spend $8.8M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Twitter (TWTR) Logo
Twitter (TWTR)
98
Autonomous Planning Logo
Autonomous Planning
96
Hybrid AI Logo
Hybrid AI
95

Active Website Tech Count

19Century Therapeutics is actively using 19 technologies for its website, according to BuiltWith. These include SPF, U.S. Server Location, and  DMARC.

Total IP

21The intellectual property of Century Therapeutics includes 21 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Century Therapeutics's headquarters? Century Therapeutics is located in Philadelphia, Pennsylvania, United States.Who invested in Century Therapeutics? Century Therapeutics has 25 investors including RA Capital Management and  T1D Fund.When was the last funding round for Century Therapeutics? Century Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Century Therapeutics's competitors? Alternatives and possible competitors to Century Therapeutics may include Calidi Biotherapeutics, Canton Strategic Holdings, and  HAYA Therapeutics.How much funding has Century Therapeutics raised to date? Century Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|